AI Signal & Stock Analysis · Avoid ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for VTRS is Avoid ↓; the stock is at $16.21 (+1.06% today); neutral (RSI 41); technical trend is down-trend; news sentiment is nan.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Avoid ↓ |
|---|---|
| Price | $16.21 |
| Change today | +1.06% |
| RSI (14) | 40.81 |
| Relative volume | 0.40 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $18.6B |
| Forward P/E | 6.08 |
| 52-week high | -11.9% away |
| 52-week low | +72.0% above |
| Technical trend | Down-trend (since 2026-05-27) |
| News sentiment | Nan |
| Sector | Healthcare-Pharma |
| Next earnings | 8/6/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns VTRS (Viatris Inc) a Avoid signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
VTRS's RSI is neutral (RSI 41). A reading above 70 is typically considered overbought and below 30 oversold.
VTRS is trading about 12% below its 52-week high and 72% above its 52-week low as of Aug 14 2026, 1:04 PM.
VTRS's next earnings date is 8/6/2026 8:30:00 AM.
VTRS is classified under Healthcare-Pharma in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.